Investigating How the Brain Processes Different Experiences
Advancing Our Understanding and Treatment of Anxiety Through Bringing Together Facets of Conscious Experience and Brain Mechanisms: Open/Closed Meets the Default Mode Network
1 other identifier
interventional
125
1 country
1
Brief Summary
The goal of this clinical trial is to test the efficacy of an app-based program in reducing anxiety and exploring associated changes in brain activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Oct 2023
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
September 22, 2023
CompletedStudy Start
First participant enrolled
October 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedMarch 15, 2024
March 1, 2024
1.3 years
September 18, 2023
March 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in GAD - 7
Generalized Anxiety Disorder 7-items (GAD-7). The GAD-7 is a validated 7-item measure of anxiety rated on a 4-point Likert scale ranging from 0 (Not at all sure) to 3 (Nearly every day).
collected at baseline and 2 month follow up apt
Change From Baseline in Posterior Cingulate Cortex (PCC) Blood Oxygen Level Dependent (BOLD) Signal
BOLD signal change will be measured by fMRI and analyzed using statistical parametric mapping
collected at baseline and 2 month follow up apt
Secondary Outcomes (2)
Penn State Worry Questionnaire (PSWQ)
collected at baseline and 2 month follow up apt
Five Facet Mindfulness Questionnaire (FFMQ) non-reactivity scale
collected at baseline and 2 month follow up apt
Other Outcomes (5)
Multidimensional Assessment of Interoceptive Awareness (MAIA)
collected at baseline and 2 month follow up apt
Anxiety Sensitivity Index (ASI)
collected at baseline and 2 month follow up apt
Interest (I) Type and Deprivation (D) Type scale (I/D)
collected at baseline and 2 month follow up apt
- +2 more other outcomes
Study Arms (2)
App-Delivered Mindfulness Training (MT)
EXPERIMENTALThe program is delivered via a smartphone-based platform, which includes a progression through 30+ daily modules of brief didactic and experience-based mindfulness training (videos and animations), app-triggered check-ins to encourage engagement, and user-initiated guided mindfulness exercises to help disrupt worry cycles in the moment.
App-Delivered Coloring
ACTIVE COMPARATORAn app-based coloring book with a variety of designs to choose from including mandalas, animal patterns, and florals. It is designed to help individuals relax and reduce stress and anxiety based on the benefits found in past research studies.
Interventions
The program is delivered via a smartphone-based platform, which includes a progression through 30+ daily modules of brief didactic and experience-based mindfulness training (videos and animations), app-triggered check-ins to encourage engagement, and user-initiated guided mindfulness exercises to help disrupt worry cycles in the moment.
An app-based coloring book with a variety of designs to choose from including mandalas, animal patterns, and florals. It is designed to help individuals relax and reduce stress and anxiety based on the benefits found in past research studies.
Eligibility Criteria
You may qualify if:
- years
- Able to travel to Brown University for research assessment
- Able to speak English because all study activities will be conducted in English.
- GAD-7 ≥ 10
- Owns a smartphone
You may not qualify if:
- If using psychotropic medication - not on a stable dosage at least 6 weeks
- As needed (i.e., prn) benzodiazepine use
- Psychotic disorder (e.g., bipolar disorder, schizophrenia, schizoaffective disorder, psychosis)
- MRI contraindications
- Claustrophobia
- Recreational drug use past 2 weeks
- Alcohol abuse
- Pregnancy or plans to become pregnant
- Cohabiting with a study participant
- Weight ≥ 300 lbs (due to inability to fit in scanner)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- Dartmouth Collegecollaborator
- Tiny Blue Dot Foundationcollaborator
Study Sites (1)
Brown University
Providence, Rhode Island, 02903, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Judson Brewer, MD, PhD
Brown University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2023
First Posted
September 22, 2023
Study Start
October 5, 2023
Primary Completion
January 31, 2025
Study Completion
March 31, 2025
Last Updated
March 15, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share